bioRxivNeurosciencePreprint
Poly(ADP-ribose) induces α-synuclein aggregation in neuronal-like cells andinteracts with phosphorylated α-synuclein in post mortem PD samples
Laura N. Puentes, Zsofia Lengyel‐ZhandiD, Ji Youn LeeiD, Chia‐Ju HsiehiD, Mark E. Schneider, Kimberly J. EdwardsiD, Kelvin C. LukiD, Virginia M.‐Y. LeeiD, John Q. TrojanowskiiD, Robert H. MachiD
Abstract
BackgroundPoly (ADP-ribose) (PAR) is a negatively charged polymer that is biosynthesized by Poly (ADP-ribose) Polymerase-1 (PARP-1) and regulates various cellular processes. Alpha-synuclein (Syn) is an intrinsically disordered protein (IDP) that has been directly implicated with driving the onset and progression of Parkinsons disease (PD). The mechanisms by which Syn elicits its neurotoxic effects remain unclear. Recent findings indicate that one of the key processes driving PD pathology are oligomeric species of Syn. Furthermore, it is well established that the main components of Lewy bodies (LBs) and Lewy neurites (LNs) in PD patients are aggregated hyperphosphorylated (S129) forms of Syn (pSyn). MethodsWe used biochemical and immunofluorescence-based assays to explore if PARP-1 enzymatic product (PAR) drives the conversion of monomeric Syn into aggregated assemblies. We performed quantitative measurements using in situ proximity ligation assays (PLA) on a transgenic murine model of -synucleinopathy (M83-SNCA*A53T) and post-mortem PD/PDD patient samples to characterize PAR-pSyn interactions. Additionally, we used bioinformatic approaches and site-directed mutagenesis to identify PAR-binding regions on fibrillar Syn. ResultsOur studies show that elevated intracellular levels of PAR promote the transition of Syn into higher molecular weight forms. We report that PAR-pSyn interactions are predominant in pathological states. Moreover, we confirm that the interactions between PAR and Syn involve electrostatic forces between negatively charged PAR and lysine residues on the N-terminal region of Syn. ConclusionsPAR plays a critical role in the early stages of monomeric Syn aggregation, thereby attributing to PD pathogenesis. Based on our results, we report that PAR seeds monomeric Syn aggregation and directly interacts with phosphorylated Syn in conditions that are pathologically relevant to PD.
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- PARylation in Parkinson's disease: a bridge between Lewy body formation and neuronal cell death
Claudia Novello, Federica Giampietro, … Samanta Mazzetti·Cell Death and DiseasePeer-reviewed·Jun 23, 2026
- WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease
Maxime Teixeira, Razan Sheta, … Abid Oueslati·bioRxiv·Apr 7, 2026
- Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?
I. A. Kuznetsov, A. V. Kuznetsov·bioRxiv·May 9, 2021
- The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is the major driver of neurodegeneration in synucleinopathies
Anne‐Laure Mahul‐Mellier, Johannes Burtscher, … Hilal Ahmed Lashuel·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 19, 2020
- Different structures and pathologies of alpha-synuclein fibrils derived from preclinical and postmortem patients of Parkinson's disease
- Low-abundance αSyn-112 promotes αSyn-140 aggregation in vitro and forms immunoreactive deposits in Parkinson's disease brain tissue
Alexander Röntgen, Giuliana Fusco, … Michele Vendruscolo·bioRxiv·Jul 9, 2026